Literature DB >> 30101992

Resveratrol promotes in vitro activation of ovine primordial follicles by reducing DNA damage and enhancing granulosa cell proliferation via phosphatidylinositol 3-kinase pathway.

Maria Éllida S Bezerra1, Bruna B Gouveia1, Ricássio S Barberino1, Vanúzia G Menezes1, Taís J S Macedo1, Agnes Y P Cavalcante1, Alane P O Monte1, Jamile M S Santos1, Maria Helena T Matos1.   

Abstract

We aimed to study the effects of resveratrol on the morphology, DNA fragmentation, follicular activation and cell proliferation after in vitro culture of ovine ovarian tissue, and to verify if PI3K pathway is involved in resveratrol action in the sheep ovary. Ovaries were collected and divided into fragments. One fragment was fixed for histology (fresh control). The remaining fragments were cultured for 7 days in control medium (α-MEM+ ) alone or with resveratrol (2, 10 or 30 µM). After culture, ovarian tissue was destined to morphological analysis. TUNEL and proliferating cell nuclear antigen (PCNA) analyses were performed in the fresh control, α-MEM+ and 2 µM resveratrol. Inhibition of PI3K activity was performed through pre-treatment with LY294002. The percentage of normal follicles was similar between α-MEM+ and 2 µM resveratrol, and higher than those in other resveratrol treatments. An increase in follicular activation was observed in all treatments compared to fresh control. DNA fragmentation decreased in tissues cultured in 2 µM resveratrol compared to α-MEM+ . Moreover, PCNA-positive cells were higher in 2 µM resveratrol than in α-MEM+ . LY294002 inhibited follicular activation stimulated by α-MEM+ and 2 µM resveratrol. In conclusion, 2 µM resveratrol promotes primordial follicle activation compared to the fresh control by reducing DNA fragmentation and stimulating granulosa cell proliferation through activation of the PI3K pathway.
© 2018 Blackwell Verlag GmbH.

Entities:  

Keywords:  PI3K; apoptosis; growth; oocyte; polyphenol

Mesh:

Substances:

Year:  2018        PMID: 30101992     DOI: 10.1111/rda.13274

Source DB:  PubMed          Journal:  Reprod Domest Anim        ISSN: 0936-6768            Impact factor:   2.005


  6 in total

Review 1.  Can Some Anticancer Treatments Preserve the Ovarian Reserve?

Authors:  Nicolas Vallet; Nicolas Boissel; Elisabeth Elefant; Florian Chevillon; Hélène Pasquer; Charlotte Calvo; Nathalie Dhedin; Catherine Poirot
Journal:  Oncologist       Date:  2021-01-29

2.  Extremely Active Nano-formulation of Resveratrol (XAR™) attenuates and reverses chemotherapy-induced damage in mice ovaries and testes.

Authors:  Sagar Chhabria; Vaishnavi Takle; Nripen Sharma; Prashant Kharkar; Kshama Pansare; Anish Tripathi; Ashish Tripathi; Deepa Bhartiya
Journal:  J Ovarian Res       Date:  2022-10-21       Impact factor: 5.506

3.  Influence of N-acetyl-L-cysteine against bisphenol a on the maturation of mouse oocytes and embryo development: in vitro study.

Authors:  Qian Li; Zhenjun Zhao
Journal:  BMC Pharmacol Toxicol       Date:  2019-07-22       Impact factor: 2.483

Review 4.  The Utilization of Physiologically Active Molecular Components of Grape Seeds and Grape Marc.

Authors:  Imre Hegedüs; Kitti Andreidesz; József L Szentpéteri; Zoltán Kaleta; László Szabó; Krisztián Szigeti; Balázs Gulyás; Parasuraman Padmanabhan; Ferenc Budan; Domokos Máthé
Journal:  Int J Mol Sci       Date:  2022-09-22       Impact factor: 6.208

Review 5.  Crosstalk between PTEN/PI3K/Akt Signalling and DNA Damage in the Oocyte: Implications for Primordial Follicle Activation, Oocyte Quality and Ageing.

Authors:  Mila Maidarti; Richard A Anderson; Evelyn E Telfer
Journal:  Cells       Date:  2020-01-14       Impact factor: 6.600

Review 6.  The Stemness of Human Ovarian Granulosa Cells and the Role of Resveratrol in the Differentiation of MSCs-A Review Based on Cellular and Molecular Knowledge.

Authors:  Malgorzata Jozkowiak; Greg Hutchings; Maurycy Jankowski; Katarzyna Kulcenty; Paul Mozdziak; Bartosz Kempisty; Robert Z Spaczynski; Hanna Piotrowska-Kempisty
Journal:  Cells       Date:  2020-06-07       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.